Andere talen Illumina, Inc.

Aandelen

ILMN

US4523271090

Geschatte realtime Cboe BZX Andere beurzen 21:24:17 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
125 ^USD	+3,94%		+6,21%	-10,23%

04:33	ILLUMINA, INC. : Bernstein handhaaft het Neutraal advies	ZM
04:12	ILLUMINA, INC. : Baird is Neutraal over het aandeel	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Illumina : 2024 Assurance Statement	18:38
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	16/04
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	16/04
Illumina's planned divestment of GRAIL approved by the European Commission	15/04
The European Commission Approves Illumina's Plan to Divest Grail	15/04
Illumina's planned divestment of GRAIL approved by the European Commission	12/04
Illumina Secures European Commission's Approval for Grail Divestment	12/04
European Commission Clears Illumina's Proposed Sale of Cancer Test Maker Grail	12/04
EU approves Illumina's plan to divest cancer test maker Grail	12/04
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed	09/04
Illumina Names Ankur Dhingra as Chief Financial Officer	09/04
Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor	09/04
Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer	09/04
Illumina, Inc. Announces Chief Financial Officer Changes	09/04
Illumina, Inc. Announces Executive Changes	09/04
Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024	04/04
GRAIL Presents New Data on Galleri and Its Methylation Platform at the Annual American Association for Cancer Research Meeting	28/03
US Equity Markets Close Higher Thursday, Extending Gains From Wednesday	21/03
Illumina Shares Up After EU Court Adviser Says Antitrust Regulators Overstepped in Halting Grail Merger	21/03
Boost for Illumina as court adviser rejects EU merger powers	21/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Illumina, Inc.

Aandelen

ILMN

US4523271090

Andere talen

Filters